Katarina Ejeskär

Forskning

Publikationer

Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival

Simon Keane, Sophie Améen, Angelica Lindlöf, Katarina Ejeskär

Cell Communication and Signaling

2020. Artikel. https://doi.org/10.1186/s12964-020-00553-6 Open Access

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression

Tajana Tešan Tomić, Josefin Olausson, Anna Rehammar, Lily Deland, Andreas Muth, Katarina Ejeskär, Staffan Nilsson, Erik Kristiansson, Ola Nilsson Wassén, Frida Abel

PLoS Genetics

2020. Artikel. https://doi.org/10.1371/journal.pgen.1008803 Open Access

Drosophila model of myosin myopathy rescued by overexpression of a TRIM-protein family member

Martin Dahl-Halvarsson, Montse Olive, Malgorzata Pokrzywa, Katarina Ejeskär, Ruth H. Palmer, Anne Elisabeth Uv, Homa Tajsharghi

Proceedings of the National Academy of Sciences of the United States of America

2018. Artikel. https://doi.org/10.1073/pnas.1800727115

Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity

Aditi Chaudhari, Katarina Ejeskär, Yvonne Wettergren, Ronald Kahn, Victoria Rotter Sopasakis

F1000 Research

2017. Artikel. https://doi.org/10.12688/f1000research.12418.2 Open Access

Verification of microRNA expression in human endometrial adenocarcinoma

Sanja Jurcevic, Karin Klinga-Levan, Björn Olsson, Katarina Ejeskär

BMC Cancer

2016. Artikel. https://doi.org/10.1186/s12885-016-2296-z Open Access

Lowered Expression of Tumor Suppressor Candidate MYO1CStimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT

Kittichate Visuttijai, Jennifer Pettersson, Yashar Mehrbani Azar, Iman van den Bout, Charlotte Örndal, Janusz Marcickiewicz, Staffan Nilsson, Michael Hörnquist, Björn Olsson, Katarina Ejeskär, Afrouz Behboudi

PLoS ONE

2016. Artikel. https://doi.org/10.1371/journal.pone.0164063 Open Access

p110 alpha Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110 alpha Kinase Activity

Aditi Chaudhari, Daniel Krumlinde, Annika Lundqvist, Levent M Akyurek, Sashidhar Bandaru, Kristina Skalen, Marcus Stahlman, Jan Boren, Yvonne Wettergren, Katarina Ejeskär, Victoria Rotter Sopasakis

Molecular and Cellular Biology

2015. Artikel. https://doi.org/10.1128/MCB.00471-15

p110α hot spot mutations E545K and H1047R exert metabolic reprogramming independently of p110α kinase activity

Aditi Chaudhari, Daniel Krumlinde, Annika Lundqvist, Levent M. Akyürek, Sashidhar Bandaru, Kristina Skålén, Marcus Ståhlman, Jan Borén, Yvonne Wettergren, Katarina Ejeskär, Victoria Rotter Sopasakis

Molecular and Cellular Biology

2015. Artikel. https://doi.org/10.1128/MCB.00471-15

The unique non-catalytic C-terminus of p37delta-PI3K adds proliferative properties in vitro and in vivo

Katarina Ejeskär, Oscar Vickes, Arunakar Kuchipudi, Yvonne Wettergren, Anne Uv, Victoria Rotter Sopasakis

PLoS ONE

2015. Artikel. https://doi.org/10.1371/journal.pone.0127497 Open Access

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma

Susanne Fransson, Frida Abel, Per Kogner, Tommy Martinsson, Katarina Ejeskär

International Journal of Oncology

2013. Artikel. https://doi.org/10.3892/ijo.2012.1732

High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival

Susanne Fransson, Katarina Ejeskär